Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

Details for Australian Patent Application No. 2009279944 (hide)

Owner Biomarin Pharmaceutical Inc.

Inventors Wang, Bing; Chu, Daniel

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009279944

PCT Pub. Number WO2010/017055

Priority 61/173,088 27.04.09 US; 61/151,036 09.02.09 US; 61/086,687 06.08.08 US

Filing date 27 July 2009

Wipo publication date 11 February 2010

International Classifications

C07D 487/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/50 (2006.01) - Pyridazines

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/02 (2006.01) Drugs for disorders of the cardiovascular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 487/12 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

3 March 2011 PCT application entered the National Phase

  PCT publication WO2010/017055 Priority application(s): WO2010/017055

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009279949-Urea derivatives as antibacterial agents

2009279940-Novel phenylamino isonicotinamide compounds